secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nemaura Medical Inc. (—)
CIK:        0001602078
Form:       8-K
Filed at:   2023-04-07T23:59:59+00:00
Accession:  0001079973-23-000460
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nemaura Medical receives Nasdaq deficiency notices for MVLS and bid price; 180-day cure periods
--------------------------------------------------------------------------------

- On April 3, 2023, Nasdaq notified Nemaura of noncompliance with $35M minimum market value of listed securities rule.
- On April 7, 2023, Nasdaq notified Nemaura of noncompliance with $1.00 minimum bid price requirement.
- Company has 180 calendar days (until October 2/3, 2023) to regain compliance on each deficiency.
- Deficiencies have no immediate effect on listing or trading of NMRD common stock on Nasdaq.
- Company is evaluating alternatives but no decisions made; compliance not assured.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1602078/000107997323000460/0001079973-23-000460-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1602078/000107997323000460/nmra_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-23-000460

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer